Collplant Biotechnologies Ltd
NASDAQ:CLGN
Income Statement
Earnings Waterfall
Collplant Biotechnologies Ltd
Income Statement
Collplant Biotechnologies Ltd
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Revenue |
2
N/A
|
2
+1%
|
3
+9%
|
6
+136%
|
6
+2%
|
5
-12%
|
1
-74%
|
16
+1 025%
|
1
-92%
|
1
-51%
|
1
-5%
|
0
-46%
|
1
+123%
|
11
+1 509%
|
11
-1%
|
11
+2%
|
11
-3%
|
1
-94%
|
1
-6%
|
1
-21%
|
2
+380%
|
2
-3%
|
2
+3%
|
|
| Gross Profit | ||||||||||||||||||||||||
| Cost of Revenue |
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
-11%
|
0
-15%
|
3
+812%
|
3
+4%
|
3
+2%
|
0
-85%
|
14
+2 817%
|
0
-100%
|
(0)
N/A
|
(0)
-89%
|
0
N/A
|
(0)
N/A
|
10
N/A
|
9
-1%
|
10
+4%
|
8
-14%
|
(1)
N/A
|
(1)
-2%
|
(1)
+44%
|
1
N/A
|
1
+23%
|
2
+5%
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(8)
|
(9)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(16)
|
(17)
|
(17)
|
(17)
|
(16)
|
(16)
|
(15)
|
(14)
|
|
| Selling, General & Administrative |
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
|
| Research & Development |
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(10)
|
(10)
|
(9)
|
|
| Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(8)
N/A
|
(8)
-2%
|
(8)
-2%
|
(5)
+31%
|
(6)
-2%
|
(5)
+10%
|
(9)
-76%
|
0
N/A
|
(14)
N/A
|
(15)
-8%
|
(16)
-9%
|
(17)
-4%
|
(17)
0%
|
(7)
+59%
|
(7)
-2%
|
(7)
+7%
|
(8)
-25%
|
(18)
-121%
|
(18)
+0%
|
(17)
+8%
|
(15)
+14%
|
(13)
+8%
|
(12)
+8%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
(3)
|
(3)
|
(3)
|
(2)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(11)
N/A
|
(11)
+6%
|
(11)
-7%
|
(7)
+34%
|
(6)
+22%
|
(5)
+9%
|
(9)
-72%
|
0
N/A
|
(14)
N/A
|
(15)
-9%
|
(16)
-9%
|
(17)
-4%
|
(17)
+1%
|
(7)
+60%
|
(7)
+0%
|
(7)
-4%
|
(8)
-7%
|
(17)
-133%
|
(17)
+0%
|
(17)
+5%
|
(14)
+17%
|
(13)
+6%
|
(12)
+6%
|
|
| Net Income | ||||||||||||||||||||||||
| Income from Continuing Operations |
(11)
|
(11)
|
(11)
|
(7)
|
(6)
|
(5)
|
(9)
|
0
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(7)
|
(7)
|
(7)
|
(8)
|
(17)
|
(17)
|
(17)
|
(14)
|
(13)
|
(12)
|
|
| Net Income (Common) |
(11)
N/A
|
(11)
+6%
|
(11)
-7%
|
(7)
+34%
|
(6)
+22%
|
(5)
+9%
|
(9)
-72%
|
0
N/A
|
(14)
N/A
|
(15)
-9%
|
(16)
-9%
|
(17)
-4%
|
(17)
+1%
|
(7)
+60%
|
(7)
+0%
|
(7)
-4%
|
(8)
-7%
|
(17)
-133%
|
(17)
+0%
|
(17)
+5%
|
(14)
+17%
|
(13)
+6%
|
(12)
+6%
|
|
| EPS (Diluted) |
-2.24
N/A
|
-1.58
+29%
|
-1.61
-2%
|
-1.05
+35%
|
-0.84
+20%
|
-0.51
+39%
|
-0.86
-69%
|
0.02
N/A
|
-1.27
N/A
|
-1.35
-6%
|
-1.46
-8%
|
-1.53
-5%
|
-1.5
+2%
|
-0.57
+62%
|
-0.58
-2%
|
-0.62
-7%
|
-0.67
-8%
|
-1.53
-128%
|
-1.52
+1%
|
-1.45
+5%
|
-1.21
+17%
|
-1.09
+10%
|
-0.95
+13%
|
|